Precision BioSciences Statistics
Share Statistics
Precision BioSciences has 7.95M shares outstanding. The number of shares has increased by 10.91% in one year.
| Shares Outstanding | 7.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 6.05% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.29M |
| Failed to Deliver (FTD) Shares | 1.08K |
| FTD / Avg. Volume | 0.23% |
Short Selling Information
The latest short interest is 274.49K, so 3.58% of the outstanding shares have been sold short.
| Short Interest | 274.49K |
| Short % of Shares Out | 3.58% |
| Short % of Float | 3.89% |
| Short Ratio (days to cover) | 2.78 |
Valuation Ratios
The PE ratio is -0.69 and the forward PE ratio is -1.23.
| PE Ratio | -0.69 |
| Forward PE | -1.23 |
| PS Ratio | 0.86 |
| Forward PS | 1.4 |
| PB Ratio | 2.23 |
| P/FCF Ratio | -0.49 |
| PEG Ratio | n/a |
Enterprise Valuation
Precision BioSciences Inc. has an Enterprise Value (EV) of -43.35M.
| EV / Earnings | 0.71 |
| EV / Sales | -0.89 |
| EV / EBITDA | 1.35 |
| EV / EBIT | 0.99 |
| EV / FCF | 0.5 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 1.19.
| Current Ratio | 2.73 |
| Quick Ratio | 2.73 |
| Debt / Equity | 1.19 |
| Total Debt / Capitalization | 54.3 |
| Cash Flow / Debt | -3.75 |
| Interest Coverage | -19.61 |
Financial Efficiency
Return on equity (ROE) is -3.25% and return on capital (ROIC) is -87.25%.
| Return on Equity (ROE) | -3.25% |
| Return on Assets (ROA) | -0.38% |
| Return on Capital (ROIC) | -87.25% |
| Revenue Per Employee | 451.18K |
| Profits Per Employee | -567.77K |
| Employee Count | 108 |
| Asset Turnover | 0.3 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -55.56% in the last 52 weeks. The beta is 1.69, so Precision BioSciences 's price volatility has been higher than the market average.
| Beta | 1.69 |
| 52-Week Price Change | -55.56% |
| 50-Day Moving Average | 6.26 |
| 200-Day Moving Average | 9.4 |
| Relative Strength Index (RSI) | 50.76 |
| Average Volume (20 Days) | 460.61K |
Income Statement
In the last 12 months, Precision BioSciences had revenue of 48.73M and earned -61.32M in profits. Earnings per share was -15.96.
| Revenue | 48.73M |
| Gross Profit | 40.47M |
| Operating Income | -43.74M |
| Net Income | -61.32M |
| EBITDA | -32.04M |
| EBIT | -43.74M |
| Earnings Per Share (EPS) | -15.96 |
Balance Sheet
The company has 116.68M in cash and 31.27M in debt, giving a net cash position of 85.41M.
| Cash & Cash Equivalents | 116.68M |
| Total Debt | 31.27M |
| Net Cash | 85.41M |
| Retained Earnings | -489.63M |
| Total Assets | 153.26M |
| Working Capital | 98.54M |
Cash Flow
In the last 12 months, operating cash flow was -84.11M and capital expenditures -2.28M, giving a free cash flow of -86.39M.
| Operating Cash Flow | -84.11M |
| Capital Expenditures | -2.28M |
| Free Cash Flow | -86.39M |
| FCF Per Share | -22.49 |
Margins
Gross margin is 83.06%, with operating and profit margins of -89.76% and -125.84%.
| Gross Margin | 83.06% |
| Operating Margin | -89.76% |
| Pretax Margin | -87.28% |
| Profit Margin | -125.84% |
| EBITDA Margin | -65.76% |
| EBIT Margin | -89.76% |
| FCF Margin | -177.3% |
Dividends & Yields
DTIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -295.56% |
| FCF Yield | -201.21% |
Analyst Forecast
The average price target for DTIL is $34, which is 529.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $34 |
| Price Target Difference | 529.6% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Feb 14, 2024. It was a backward split with a ratio of 1:30.
| Last Split Date | Feb 14, 2024 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -2.45 |
| Piotroski F-Score | 4 |